BLOG

Thursday, November 1, 2018

Strides Pharma Q2 net loss at Rs 87 million on poor operating income

Consolidated revenue also saw a marginal degrowth of 4.6 per cent at Rs 7.3 billion

from Companies https://ift.tt/2Oi8TlM
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...